NCT04075435

Who might be able to join this trial:

• You have been diagnosed with probable Alzheimer's disease or mild cognitive impairment (MCI)
• You scored between 15 and 30 (inclusive) on a standard memory and thinking test called the MMSE
• You have a clinically significant level of anxiety, based on a specific rating scale used by the study team
• You have someone available (such as a family member or legal representative) who can sign consent forms on your behalf if needed
• You have a caregiver who spends at least 10 hours per week with you and is able to attend all study appointments
• Both you and your study partner (caregiver) must be fluent in English
• You are between 55 and 90 years old (inclusive)

Who may not be able to join:

• You have a serious or unstable illness affecting the heart, liver, kidneys, lungs, hormones, nervous system, or blood that could interfere with the study
• You have a seizure disorder (such as epilepsy)
• You have ever been diagnosed with bipolar disorder, schizophrenia, or schizoaffective disorder
• You are currently experiencing a major depressive episode
• You have had a problem with alcohol or drug misuse or dependence in the past 6 months
• You are currently experiencing delirium (sudden severe confusion), as measured by the study team
• You are currently admitted to a hospital
• You currently use cannabis or cannabinoid products more than once a month
• You test positive for THC (the active substance in cannabis) in a urine test at the screening or first study visit
• You have an allergy to coconut
• You are currently taking certain medications that strongly affect how the body processes drugs, including some antifungals, antidepressants, antibiotics, herbal supplements (such as St. John's Wort), or anti-epileptic drugs (confirm with trial site for the full list of affected medications)

Important: Always verify eligibility with the trial site directly before applying.